EBS
Emergent BioSolutions Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.36
−0.31%Leverage
- Debt / equity
- 1.70x
- Net debt / equity
- 1.29x
- Debt / assets
- 0.52x
- Debt / EBITDA
- -831.14x
- Net debt / EBITDA
- -631.57x
Liquidity & coverage
- Current ratio
- 5.42x
- Quick ratio
- 2.95x
- Cash ratio
- 1.14x
- Interest coverage
- -1.07x
- EBITDA / interest
- -0.01x
- Working capital
- $543.2M
Cash & dividend
- FCF / debt
- 0.15x
- Cash flow / debt
- 0.17x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026